Membrane and cell wall targets in Aspergillus fumigatus

被引:55
作者
Beauvais, A [1 ]
Latgé, JP [1 ]
机构
[1] Inst Pasteur, Unite Aspergillus, F-75724 Paris 15, France
关键词
D O I
10.1054/drup.2001.0185
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antifungal drugs directed against the human opportunistic fungal pathogen Aspergillus fumigatus are limited in number and ergosterol-targeted: the polyenes bind to the membrane ergosterol and the azoles block the ergosterol biosynthesis pathway. The efficacy of the drugs currently available for clinical use (amphotericin B and itraconazole) is limited and the frequent occurrence of therapeutic failures in the treatment of invasive aspergillosis emphasizes the need for the development of new agents. Cell wall biosynthetic pathways have been recognized for a long time as essential and unique specific drug targets. Recent studies of the chemical organization of the cell wall of A. fumigatus together with comparative analysis of yeast cell wall data have shown that beta1-3 glucan branching and chitin-beta1-3 glucan binding are essential exocellular enzymatic steps in cell wall biosynthesis. The enzymes involved in the biosynthesis and remodeling of cell wall polysaccharides especially in A. fumigatus are reviewed. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:38 / 49
页数:12
相关论文
共 100 条
  • [1] In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B
    Abraham, OC
    Manavathu, EK
    Cutright, JL
    Chandrasekar, PH
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (01) : 7 - 11
  • [2] Evaluation of the echinocandin antifungal MK-0991 (L-743,872): Efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
    Abruzzo, GK
    Flattery, AM
    Gill, CJ
    Kong, L
    Smith, JG
    Pikounis, VB
    Balkovec, JM
    Bouffard, AF
    Dropinski, JF
    Rosen, H
    Kropp, H
    Bartizal, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2333 - 2338
  • [3] [Anonymous], MICROBIAL DIFFERENTI
  • [4] [Anonymous], MOL BIOL YEAST SACCH
  • [5] Aspergillus fumigatus chsE: A gene related to CHS3 of Saccharomyces cerevisiae and important for hyphal growth and conidiophore development but not pathogenicity
    AufauvreBrown, A
    Mellado, E
    Gow, NAR
    Holden, DW
    [J]. FUNGAL GENETICS AND BIOLOGY, 1997, 21 (01) : 141 - 152
  • [6] BALLOU L, 1980, J BIOL CHEM, V255, P5986
  • [7] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
    Bartizal, K
    Gill, CJ
    Abruzzo, GK
    Flattery, AM
    Kong, L
    Scott, PM
    Smith, JG
    Leighton, CE
    Bouffard, A
    Dropinski, JF
    Balkovec, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2326 - 2332
  • [8] CHARACTERIZATION OF THE 1,3-BETA-GLUCAN SYNTHASE OF ASPERGILLUS-FUMIGATUS
    BEAUVAIS, A
    DRAKE, R
    NG, K
    DIAQUIN, M
    LATGE, JP
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 : 3071 - 3078
  • [9] BEAUVAIS A, 2001, IN PRESS J BACT, P183
  • [10] AMPHOTERICIN-B - CURRENT UNDERSTANDING OF MECHANISMS OF ACTION
    BRAJTBURG, J
    POWDERLY, WG
    KOBAYASHI, GS
    MEDOFF, G
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) : 183 - 188